Urology Times reached out to four urologists (selected randomly) and asked them each the following question: Will the results of the PRECISION study change the way you diagnose prostate cancer?
“I started using MRIs 4 years ago. I don’t know that it’s a game changer, but it certainly helps. MRIs are used differently here than in the United Kingdom. In the U.S., MRIs are used more for active surveillance in the repeat biopsies realm—not to avoid biopsies. Most American urologists don’t decide to biopsy a patient based on MRI results—the most powerful predictors are still the PSA and rectal exam.
I’ve used it mostly in patients who had a prior negative biopsy, but their PSA is still rising. If they’ve had a previous PI-RADS 4 or higher lesion, I would probably target that for biopsy. If their PSA is rising slowly and their MRI is negative in the prior biopsy, I’m more likely to watch that person.
If the PRECISION study results hold up in future research, any time you can avoid an invasive procedure with risks, obviously that’s good for patients.”
Michael Darson, MD